Skip to content

Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis

Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03722537
Enrollment
200
Registered
2018-10-29
Start date
2019-11-14
Completion date
2027-03-01
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Joint Arthritis

Keywords

Allograft, Osteochondral Allograft, Arthritis

Brief summary

This is a study comparing the current standard of care surgical treatment to a newer surgical procedure involving the implantation of osteochondral allograft at the base of the thumb. Patients will be followed at 1, 3, 6 months and 1 year post-operatively.

Detailed description

Basal joint arthritis of the thumb is a common condition associated with considerable morbidity. Many non-operative and operative treatments have been described, but few multicenter prospective evidence based trials exist comparing standard treatments. This continuing search for consensus and improvement of best clinical practice has been reviewed in a thorough meta-analysis of operative treatments for basal joint arthritis. Operative treatments range from osteotomy, partial or complete trapeziectomy with or without reconstruction of the ligaments, tendon interposition to arthrodesis, however the functional outcome varies. Allograft has been previously described in joint replacement / prosthetic implantation surgery in other areas of the body, however not in the thumb. The purpose of this study is to investigate using osteochondral allograft in the surgical intervention phase of treatment for patients with basal joint arthritis.

Interventions

PROCEDUREOsteochondral Allograft

The arthritic bone that the thumb rests on (the trapezium) is removed and replaced with femoral trochlear osteochondral allograft that is designed to be similar in morphology to the human trapezium articular surface.

During the LRTI, the arthritic bone that the thumb rests on (the trapezium) is removed. A small cut is made in the forearm to release a tendon, which is moved to the base of the thumb to fill in the area from which the trapezium bone was removed. A small suture anchor is then placed into a thumb bone which holds everything together.

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Indicated for operative management of basal joint arthritis

Exclusion criteria

* Pregnant women/fetuses/neonates, prisoners * Previously operated on for treatment of basal joint arthritis

Design outcomes

Primary

MeasureTime frameDescription
Score on the Disabilities of the Arm, Shoulder, and Hand (DASH) QuestionnaireUp to 1 year post-operativelyThe DASH (Disabilities of the Arm, Shoulder, and Hand) is a 30-item questionnaire that includes 21 physical function items, 6 symptom items, and 3 social/role function items used to evaluate a patient's ability to perform upper extremity activities. Higher scores indicate a greater level of disability and severity, whereas, lower scores indicate a lower level of disability. The score on both test ranges from 0 (no disability) to 100 (most severe disability).

Secondary

MeasureTime frameDescription
Score on the Thumb Disability Exam (TDX)Up to 1 year post-operativelyThe TDX is a questionnaire that measures changes in thumb function and pain, specifically for those with basal joint arthritis.The TDX is scored on a scale of 0 to 100, with a higher score indicating a greater degree of disability in the thumb.
Visual Analog Scale for pain (VAS)Up to 1 year post-operativelyThe VAS is a validated technique that measures acute and chronic pain. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Countries

United States

Contacts

CONTACTMelvin P Rosenwasser, MD
mpr2@cumc.columbia.edu212-305-8036
PRINCIPAL_INVESTIGATORMelvin P Rosenwasser, MD

Columbia University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026